Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Koninklijke Philips N.V.

Latest From Koninklijke Philips N.V.

Extraordinary Times Call For Exceptional Response From Philips’ Connected Care Chief

Roy Jakobs was appointed internally to head connected care at Philips on 28 January, shortly before COVID-19 forced the first of many lockdowns around the world. The disruption prompted a rapid rethink of priorities, which has shown opportunities for lasting health care system change.

Leadership Coronavirus COVID-19

Change Is Coming In Health Care, If Not Yet At The Speeds Of Other Consumer Industries

The advent of COVID-19 and its effects on care delivery have meant that short-term priorities for health care systems have switched temporarily to public health emergency mode. But the longer-term need to restructure delivery around outcomes and federated data management for patients is here to stay, says Royal Philips’ Jeroen Tas.

Business Strategies Commercial

Philips Augments HealthSuite With New Clinical Trials Offering

Philips has added a Clinical Trials Accelerator functionality to the cloud-based HealthSuite digital platform, underlining its role in securely managing and collecting device and personal data for use by third-party clients seeking to build health care solutions.

Commercial Clinical Trials

$2Bn Golden Egg: 8 Manufacturers Will Share Billions To Make Ventilators For US Govt

Seven companies – GE, Medtronic, ResMed, Hill-Rom, Vyaire, Hamilton Medical and Zoll – will manufacture 64,431 medical ventilators under the Defense Production Act at a cost of more than $1.4bn, the US Department of Health and Human Services said on 13 April. That figure, when combined with the $646.7m recently awarded to Royal Philips to make 45,500 vents, means the US government will spend more than $2bn on the devices.

Manufacturing Policy
See All

Company Information

  • Industry
  • Diversified
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
  • In Vitro Diagnostics
    • Biosensors
    • Chemistry, Immunoassay
  • Other Names / Subsidiaries
    • AngioScore, Inc.
    • AtheroMed
    • Axsun Technologies
    • BioTelemetry, Inc.
    • Cardiologs Technologies SAS
    • CardioProlific Inc.
    • Crux Biomedica
    • Dynalite
    • Electrical Geodesics, Inc.
    • EndoSonics Corp.
    • Forcare
    • Gaggia
    • Intact Vascular Inc.
    • Kensey Nash Corp's Endovascular business unit
    • Magnavox
    • Medumo, Inc
    • Mini-Mitter
    • JOMED
    • Philips
    • PolyGram
    • Pye Ltd.
    • Remote Diagnostic Technologies LLC
    • Respironics, Inc.
    • Royal Philips
    • Saeco
    • Shenzhen Goldway Industrial
    • Spectranetics Corporation
    • Sync-RX
    • TomTec Imaging Systems GmbH
    • Upstream Peripheral Technologies, Ltd.
    • VitalHealth
    • Volcano Corporation
    • Xhale Assurance, Inc.